Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

# Resources

Primary Central Nervous System Lymphoma – Symptoms, Treatment & Support

What is Primary Central Nervous System Lymphoma? Primary central nervous system lymphoma is a type of cancer in which cancer cells form in the lymph tissues of the brain and spinal cord. It usually develops in people with immunodeficiency, especially in people with...

Primary Cardiac Angiosarcoma – Symptoms, Treatment & Support

What is primary cardiac angiosarcoma? Primary cardiac angiosarcoma is a rare type of soft tissue sarcoma that arises from the cells that make up the blood vessels of the heart. Primary cardiac angiosarcoma is an extremely rare type of tumour that is malignant...

Pleomorphic Liposarcoma – Symptoms, Treatment & Support

What is Pleomorphic liposarcoma? Pleomorphic liposarcoma is a rare subtype of fat cell cancer in the body. It is a rare and very malignant type of tumor that usually arises from fat cells and deep soft tissues of the upper and lower extremities (shoulder, arms, legs,...

Nasopharyngeal Adenoid Cystic Carcinoma – Symptoms, Treatment & Support

What is Nasopharyngeal Adenoid Cystic Carcinoma? Adenoid cystic carcinoma of the nasopharynx is a rare, slowly growing aggressive tumour with a high tendency to relapse. It also tends to metastasize (spread to other parts of the body from its place of origin) to other...

Lymphoepithelioma (Urinary Bladder) – Symptoms, Treatment & Support

What is lymphoepithelioma like carcinoma of the urinary bladder? Lymphoepithelioma-like carcinoma of the urinary bladder is a rare subtype of transitional cell carcinoma or urothelial carcinoma. It is characterized by the uncontrolled multiplication of certain types...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2026. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter